Pyrazine derivatives: a patent review (June 2012-present)

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F15%3A10293779" target="_blank" >RIV/00216208:11160/15:10293779 - isvavai.cz</a>

Result on the web

<a href="http://www.tandfonline.com/doi/full/10.1517/13543776.2014.982533" target="_blank" >http://www.tandfonline.com/doi/full/10.1517/13543776.2014.982533</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1517/13543776.2014.982533" target="_blank" >10.1517/13543776.2014.982533</a>

Result language

angličtina

Original language name

Pyrazine derivatives: a patent review (June 2012-present)

Original language description

Introduction: Pyrazine is amember of 1,4-diazines, which constitute an important class of heterocycles. Various pyrazine derivatives have been synthesized and successfully evaluated as agents with diverse pharmacological effects (including but not limited to antiproliferative, anti-infective, and effects on cardiovascular or nervous system) and some of them have become clinically used drugs worldwide. Area covered: This review is a survey of important patents on pyrazine derivatives with pharmacologicalactivity published in the period June 2012 - July 2014. The patent databases SciFinder and esp@cenet were used to locate patent applications. Expert opinion: Pyrazine derivatives possess numerous noteworthy pharmacological effects, including antimycobacterial, antibacterial, antifungal, antidiabetic, diuretic, anticancer, antiviral, hypnotic, and analgesic. The class of pyrazine-based candidate drugs has experienced a rapid growth both in absolute numbers of investigated compounds and i

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FR - Pharmacology and apothecary chemistry

OECD FORD branch

—

Project

<a href="/en/project/EE2.3.30.0022" target="_blank" >EE2.3.30.0022: Support of establishment, development, and mobility of quality research teams at the Charles University</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2015

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Expert Opinion on Therapeutic Patents

ISSN

1354-3776

e-ISSN

—

Volume of the periodical

25

Issue of the periodical within the volume

1

Country of publishing house

GB - UNITED KINGDOM

Number of pages

15

Pages from-to

33-47

UT code for WoS article

000346742700004

EID of the result in the Scopus database

2-s2.0-84919459415